BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.65	21.79	12.11	7.98	7.86	18.04
Short-Term Investments	4.25	6.86	3.83	18.2	20.83	10.18
Cash & Short-Term Investments	10.9	28.65	15.94	26.19	28.7	28.21
Cash Growth	-37.36%	79.74%	-39.13%	-8.74%	1.71%	10.30%
Accounts Receivable	7.49	4.46	2.91	3.48	3.5	2.79
Other Receivables	0.06	0.08	0.09	0.07	0.16	0.42
Total Trade Receivables	7.55	4.54	2.99	3.55	3.66	3.21
Inventory	11.29	6.42	5.33	5.89	4.54	2.2
Other Current Assets	1.58	0.19	0.21	0.24	0.25	0.46
Total Current Assets	31.32	39.79	24.47	35.87	37.14	34.08
Net Property, Plant & Equipment	1.71	0.98	1.2	1.44	1.67	1.93
Other Intangible Assets	21.83	4.8	5.04	1.15	1.2	0.87
Goodwill	3.75	-	-	-	-	-
Long-Term Investments	3.36	3.36	10.24	2.71	0.26	0.18
Other Long-Term Assets	0.53	0.51	0.4	0.36	0.21	0.1
Total Assets	62.49	49.44	41.36	41.53	40.49	37.17
Accounts Payable	8.1	6.15	4	5.08	5.06	3.56
Short-Term Debt	4	-	-	-	-	-
Current Portion of Leases	0.43	0.21	0.2	0.18	0.17	0.16
Unearned Revenue	0.94	0.42	0.81	0.13	0.16	0.31
Other Current Liabilities	3.09	0.43	0.4	0.14	0.32	0.1
Total Current Liabilities	16.56	7.22	5.41	5.53	5.72	4.14
Long-Term Leases	0.81	0.63	0.84	1.04	1.22	1.4
Other Long-Term Liabilities	0.12	0.13	0.11	0.2	0.18	0.08
Total Long-Term Liabilities	0.93	0.76	0.95	1.24	1.4	1.48
Total Liabilities	17.5	7.97	6.36	6.77	7.12	5.61
Common Stock	8.72	5.25	5.31	5.12	5.37	5.8
Additional Paid-in Capital	1.8	2.16	2.14	2.29	2.23	1.82
Accumulated Other Comprehensive Income	-0.15	-0.18	-0.17	-0.18	-0.14	-0.19
Retained Earnings	34.63	34.24	27.73	27.53	25.91	24.12
Shareholders' Equity	44.99	41.47	35	34.76	33.36	31.55
Total Liabilities & Equity	62.49	49.44	41.36	41.53	40.49	37.17
Total Debt	5.25	0.84	1.04	1.22	1.4	1.56
Net Cash (Debt)	5.65	27.81	14.9	24.97	27.3	26.65
Net Cash Growth	-79.67%	86.61%	-40.31%	-8.55%	2.42%	11.67%
Net Cash Per Share	0.49	2.42	1.26	2.05	2.18	2.07
Book Value	44.99	41.47	35	34.76	33.36	31.55
Book Value Per Share	3.90	3.60	2.96	2.86	2.66	2.45
Tangible Book Value	19.42	36.67	29.96	33.61	32.16	30.68
Tangible Book Value Per Share	1.68	3.19	2.54	2.76	2.56	2.38

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.